The COVID-19 pandemic and the use of MS disease-modifying therapies

Saved in:

Bibliographic Details
Published in	Multiple sclerosis and related disorders Vol. 39; p. 102073
Main Authors	Giovannoni, Gavin, Hawkes, Chris, Lechner-Scott, Jeannette, Levy, Michael, Waubant, Emmanuelle, Gold, Julian
Format	Journal Article
Language	English
Published	Netherlands Elsevier B.V 01.04.2020
Subjects	Betacoronavirus - isolation & purification Coronavirus Infections - epidemiology Coronavirus Infections - immunology Coronavirus Infections - prevention & control COVID-19 Humans Multiple Sclerosis - drug therapy Multiple Sclerosis - epidemiology Multiple Sclerosis - immunology Multiple Sclerosis - virology Neurology Pandemics - prevention & control Pneumonia, Viral - epidemiology Pneumonia, Viral - immunology Pneumonia, Viral - prevention & control SARS-CoV-2
Online Access	Get full text
ISSN	2211-0348 2211-0356 2211-0356
DOI	10.1016/j.msard.2020.102073

More Information
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	2211-0348 2211-0356 2211-0356
DOI:	10.1016/j.msard.2020.102073